New hope for stubborn blood sugar? major trial tests third diabetes pill
NCT ID NCT06571591
Summary
This study is testing if adding a medication called pioglitazone helps adults with type 2 diabetes who still have high blood sugar despite taking two common drugs (metformin and empagliflozin). Researchers will compare pioglitazone to a placebo (dummy pill) in about 580 people to see if it better controls blood sugar levels and is safe. The goal is to see if this three-drug combination offers better long-term disease management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celltrion
Incheon, South Korea
Conditions
Explore the condition pages connected to this study.